Subsequent overexpression of TIGAR in HNSCC cells eliminated the growth inhibitory effects of c-Met inhibitors, while also reportedly upregulating mesenchymal markers such as vimentin [63,64]. This evidence concerns the gene TIGAR and head and neck squamous cell carcinoma.